| E-DII score negative (n = 113) | E-DII score positive (n = 64) | p value | Effect size |
---|---|---|---|---|
Women | 103 (91) | 48 (75) | 0.007 | 0.22 |
Age (years) | 62.0 (17.0) | 59.5 (25.0) | 0.13 | 0.09 |
Height (cm) | 154.5 (9.9) | 156.7 (13.5) | 0.19 | 0.09 |
Weight (kg) | 52.3 (13.4) | 55.5 (15.1) | 0.017 | 0.12 |
BMI (kg/m2) | 22.0 (5.3) | 22.9 (5.1) | 0.06 | 0.10 |
Smoking | 27 (24) | 24 (38) | 0.06 | 0.14 |
Drinking habits | 42 (37) | 36 (56) | 0.018 | 0.19 |
RF (IU/ml) | 46 (108) | 40 (89) | 0.49 | 0.06 |
RF positive | 86 (76) | 48 (75) | 0.86 | 0.01 |
Anti-CCP (U/ml) | 61.1 (86.2) | 88.5 (89.9) | 0.45 | 0.07 |
Anti-CCP positive | 94 (83) | 58 (91) | 0.26 | 0.10 |
RA duration (years) | 12.2 (17.4) | 8.1 (12.5) | 0.037 | 0.11 |
csDMARD user | 102 (90) | 60 (94) | 0.58 | 0.06 |
bDMARD user | 65 (58) | 39 (61) | 0.75 | 0.03 |
GC user | 27 (24) | 20 (31) | 0.29 | 0.08 |
ESR (mm/h) | 23 (27) | 16 (25) | 0.005 | 0.13 |
MMP-3 (ng/ml) | 60.8 (63.0) | 72.3 (93.8) | 0.33 | 0.07 |
hs-CRP (mg/l) | 0.13 (0.36) | 0.09 (0.43) | 0.72 | 0.05 |
mHAQ-DI | 0.25 (0.81) | 0.25 (0.97) | 0.43 | 0.07 |
TJC | 2 (6) | 1 (3) | 0.06 | 0.10 |
SJC | 0 (2) | 0 (2) | 0.44 | 0.07 |
Patient VAS | 30 (40) | 24 (40) | 0.60 | 0.05 |
DAS28-ESR | 3.6 (2.2) | 3.2 (1.7) | 0.007 | 0.12 |